Fri, April 21, 2023
Thu, April 20, 2023
Wed, April 19, 2023

Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $87 on, Apr 20th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-87-on-apr-20th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Tsao of HC Wainwright & Co., Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $87 on, Apr 20th, 2023.

Douglas has made no other calls on APLS in the last 4 months.



There are 8 other peers that have a rating on APLS. Out of the 8 peers that are also analyzing APLS, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, April 17th, 2023
  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $58 on, Tuesday, January 3rd, 2023


These are the ratings of the 6 analyists that currently disagree with Douglas


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $139 on, Wednesday, February 22nd, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy and Held Target at $80 on, Wednesday, February 22nd, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, February 21st, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $105 on, Tuesday, February 21st, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Tuesday, February 21st, 2023

Publication Contributing Sources